Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified.
Saved in:
| Title: | Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified. |
|---|---|
| Authors: | Esler, Murray1 (AUTHOR), Kjeldsen, Sverre E.2 (AUTHOR), Pathak, Atul3 (AUTHOR), Grassi, Guido4 (AUTHOR), Kreutz, Reinhold5 (AUTHOR), Mancia, Giuseppe4 (AUTHOR) |
| Source: | Blood Pressure. Dec2022, Vol. 31 Issue 1, p210-224. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 160300921 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Esler%2C+Murray%22">Esler, Murray</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kjeldsen%2C+Sverre+E%2E%22">Kjeldsen, Sverre E.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pathak%2C+Atul%22">Pathak, Atul</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Grassi%2C+Guido%22">Grassi, Guido</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kreutz%2C+Reinhold%22">Kreutz, Reinhold</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mancia%2C+Giuseppe%22">Mancia, Giuseppe</searchLink><relatesTo>4</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Blood+Pressure%22">Blood Pressure</searchLink>. Dec2022, Vol. 31 Issue 1, p210-224. 15p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=160300921 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/08037051.2022.2110858 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 15 StartPage: 210 Titles: – TitleFull: Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Esler, Murray – PersonEntity: Name: NameFull: Kjeldsen, Sverre E. – PersonEntity: Name: NameFull: Pathak, Atul – PersonEntity: Name: NameFull: Grassi, Guido – PersonEntity: Name: NameFull: Kreutz, Reinhold – PersonEntity: Name: NameFull: Mancia, Giuseppe IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: Dec2022 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 08037051 Numbering: – Type: volume Value: 31 – Type: issue Value: 1 Titles: – TitleFull: Blood Pressure Type: main |
| ResultId | 1 |